Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations.
4F-α-PVP
PV7
bath salt
hepatocyte metabolism
liquid chromatography–high resolution tandem mass spectrometry
novel psychoactive substance
synthetic cathinone
α-PHP
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
28 Dec 2020
28 Dec 2020
Historique:
received:
01
01
1970
revised:
24
12
2020
accepted:
25
12
2020
entrez:
31
12
2020
pubmed:
1
1
2021
medline:
11
9
2021
Statut:
epublish
Résumé
For more than ten years, new synthetic cathinones (SCs) mimicking the effects of controlled cocaine-like stimulants have flooded the illegal drug market, causing numerous intoxications and fatalities. There are often no data on the pharmacokinetics of these substances when they first emerge onto the market. However, the detection of SC metabolites is often critical in order to prove consumption in clinical and forensic settings. In this research, the metabolite profile of two pyrrolidinyl SCs, α-pyrrolidinohexaphenone (α-PHP) and 4''-fluoro-α-pyrrolidinovalerophenone (4F-α-PVP), were characterized to identify optimal intake markers. Experiments were conducted using pooled human hepatocyte incubations followed by liquid chromatography-high-resolution tandem mass spectrometry and data-mining software. We suggest α-PHP dihydroxy-pyrrolidinyl, α-PHP hexanol, α-PHP 2'-keto-pyrrolidinyl-hexanol, and α-PHP 2'-keto-pyrrolidinyl as markers of α-PHP use, and 4F-α-PVP dihydroxy-pyrrolidinyl, 4F-α-PVP hexanol, 4F-α-PVP 2'-keto-pyrrolidinyl-hexanol, and 4F-α-PVP 2'-keto-pyrrolidinyl as markers of 4F-α-PVP use. These results represent the first data available on 4F-α-PVP metabolism. The metabolic fate of α-PHP was previously studied using human liver microsomes and urine samples from α-PHP users. We identified an additional major metabolite (α-PHP dihydroxy-pyrrolidinyl) that might be crucial for documenting exposure to α-PHP. Further experiments with suitable analytical standards, which are yet to be synthesized, and authentic specimens should be conducted to confirm these results.
Identifiants
pubmed: 33379373
pii: ijms22010230
doi: 10.3390/ijms22010230
pmc: PMC7796222
pii:
doi:
Substances chimiques
Alkaloids
0
Pyrrolidines
0
alpha-pyrrolidinohexanophenone
0
alpha-pyrrolidinovalerophenone
0
cathinone
540EI4406J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health
ID : -
Organisme : Presidency of the Ministers Council, Department of Antidrug Policy
ID : F75J18000390005
Références
Drug Test Anal. 2016 Aug;8(8):779-91
pubmed: 26331297
Drug Test Anal. 2017 May;9(5):680-698
pubmed: 27448631
Drug Test Anal. 2017 Aug;9(8):1162-1171
pubmed: 27863142
Ther Drug Monit. 2020 Apr;42(2):205-221
pubmed: 31809406
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):268-274
pubmed: 29364498
Drug Test Anal. 2018 Jan 4;:
pubmed: 29314710
Forensic Sci Int. 2013 Sep 10;231(1-3):296-9
pubmed: 23890652
Pharmacol Rev. 2005 Mar;57(1):79-115
pubmed: 15734728
AAPS J. 2017 Mar;19(2):568-577
pubmed: 28070717
Forensic Sci Int. 2019 May;298:115-120
pubmed: 30897447
Clin Pharmacol Ther. 2017 Feb;101(2):239-253
pubmed: 27727455
Bioanalysis. 2016;8(1):65-82
pubmed: 26648097
Forensic Toxicol. 2017 Jan;35(1):20-32
pubmed: 28286577
Anal Bioanal Chem. 2016 Jul;408(18):4845-56
pubmed: 27185540
J Anal Toxicol. 2016 Jan-Feb;40(1):1-11
pubmed: 26294756
Clin Chem. 2017 Nov;63(11):1753-1763
pubmed: 28821542
J Mass Spectrom. 2012 Feb;47(2):253-62
pubmed: 22359337
Clin Toxicol (Phila). 2019 Feb;57(2):112-116
pubmed: 30117325
Curr Neuropharmacol. 2017 Jul;15(5):682-691
pubmed: 29403341
Ther Drug Monit. 2020 Aug 31;:
pubmed: 32881779
Forensic Toxicol. 2016;34:61-75
pubmed: 26793277
Forensic Sci Int. 2015 Apr;249:181-8
pubmed: 25703013
J Anal Toxicol. 2019 Jan 1;43(1):e1-e6
pubmed: 30060126
Curr Drug Metab. 2000 Dec;1(4):357-89
pubmed: 11465044
Clin Chem. 2017 May;63(5):1008-1021
pubmed: 28302730
Anal Chem. 2015 Nov 3;87(21):10935-41
pubmed: 26434689
J Mass Spectrom. 2009 Jun;44(6):952-64
pubmed: 19241365
J Pharm Biomed Anal. 2018 Aug 5;157:27-35
pubmed: 29754040
J Pharmacol Exp Ther. 2016 Jan;356(1):182-90
pubmed: 26645638
J Med Chem. 1970 May;13(3):497-503
pubmed: 5441133
Drug Metab Rev. 2018 May;50(2):125-139
pubmed: 29540067
Forensic Sci Int. 2014 Oct;243:1-13
pubmed: 24769262
J Mass Spectrom. 2015 Nov;50(11):1305-17
pubmed: 26505776
Front Pharmacol. 2019 Apr 24;10:438
pubmed: 31068823
Forensic Toxicol. 2018;36(2):486-497
pubmed: 29963212
Br J Pharmacol. 2015 May;172(10):2433-44
pubmed: 25438806
Psychopharmacology (Berl). 2019 Mar;236(3):939-952
pubmed: 30397775
Front Chem. 2019 Mar 04;7:109
pubmed: 30886845
Arch Toxicol. 2020 Apr;94(4):1085-1133
pubmed: 32249347
Forensic Sci Int. 2019 Aug;301:e20-e28
pubmed: 31097357
Forensic Sci Int. 2016 Feb;259:e14-9
pubmed: 26775198